FDA clears new Zenition 30 mobile C-arm from Philips
April 22, 2024
Philips (NYSE: PHG)+
announced today that the FDA granted 510(k) clearance for its Zenition 30 mobile C-arm.
Philips (NYSE: PHG)+
announced today that the FDA granted 510(k) clearance for its Zenition 30 mobile C-arm.
Lumicell developed the technology to help physicians detect residual cancer in the breast cavity after surgery.
The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD)
Scopio can now add the application to its imaging platforms that allow users to view blood samples digitally rather than under a microscope.
Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal.
The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care
IRVING, Texas, April 16, 2024 /PRNewswire/ — Xstim, Inc., a pioneering developer and manufacturer of cutting-edge bone growth stimulation systems, is thrilled to announce its recent Premarket Application (PMA) approval from the U.S. Food and Drug Administration (FDA) for Xstim™ Spine Fusion Stimulator
Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity
The 3D printed PEEK implants using the EXT 220 MED were successfully demonstrated in nearly 40 cranioplasties across Europe in recent months says the company.
FastWave Medical announced today that it received a fourth utility patent to strengthen the IP foundation of its IVL platform.